$TKNO
Alpha Teknova, Inc.

2023 Q4 Form 10-Q Financial Statement

#000095017023063053 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $7.867M $8.169M $10.69M
YoY Change -0.3% -23.6% 13.84%
Cost Of Revenue $6.532M $6.697M $5.922M
YoY Change 12.99% 13.09% 15.46%
Gross Profit $1.335M $1.472M $4.770M
YoY Change -36.73% -69.14% 11.89%
Gross Profit Margin 16.97% 18.02% 44.61%
Selling, General & Admin $8.425M $8.550M $8.899M
YoY Change -15.76% -3.92% 37.08%
% of Gross Profit 631.09% 580.84% 186.56%
Research & Development $1.311M $1.397M $1.925M
YoY Change -29.89% -27.43% 40.31%
% of Gross Profit 98.2% 94.9% 40.36%
Depreciation & Amortization $1.611M $1.300M $400.0K
YoY Change 80.4% 225.0% -20.0%
% of Gross Profit 120.67% 88.32% 8.39%
Operating Expenses $10.02M $10.23M $27.72M
YoY Change -17.55% -63.09% 240.13%
Operating Profit -$8.689M -$8.762M -$22.95M
YoY Change -13.53% -61.83% 490.38%
Interest Expense -$440.0K -$790.0K $70.00K
YoY Change -443.75% -1228.57% -127.45%
% of Operating Profit
Other Income/Expense, Net $338.0K -$1.382M $106.0K
YoY Change 1678.95% -1403.77% -141.57%
Pretax Income -$10.96M -$10.14M -$22.85M
YoY Change -22.21% -55.6% 451.48%
Income Tax -$304.0K $9.000K -$400.0K
% Of Pretax Income
Net Earnings -$10.66M -$10.15M -$22.47M
YoY Change -19.84% -54.82% 591.29%
Net Earnings / Revenue -135.45% -124.29% -210.19%
Basic Earnings Per Share -$0.34 -$0.80
Diluted Earnings Per Share -$0.26 -$0.34 -$800.1K
COMMON SHARES
Basic Shares Outstanding 40.73M 28.34M 28.09M
Diluted Shares Outstanding 29.96M 28.09M

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.59M $32.10M $49.86M
YoY Change -32.3% -35.61% -49.13%
Cash & Equivalents $28.59M $32.08M $49.86M
Short-Term Investments
Other Short-Term Assets $1.524M $2.400M $3.521M
YoY Change -35.8% -31.84% 20.83%
Inventory $11.59M $11.47M $10.32M
Prepaid Expenses
Receivables $3.948M $5.160M $5.581M
Other Receivables $0.00 $0.00 $120.0K
Total Short-Term Assets $45.66M $51.08M $70.07M
YoY Change -25.32% -27.1% -36.92%
LONG-TERM ASSETS
Property, Plant & Equipment $66.84M $51.58M $52.63M
YoY Change -6.28% -1.99% 134.41%
Goodwill $0.00
YoY Change -100.0%
Intangibles $14.24M $16.70M $17.84M
YoY Change -18.89% -6.43% -6.04%
Long-Term Investments
YoY Change
Other Assets $1.852M $1.952M $1.176M
YoY Change -17.76% 65.99% 3955.17%
Total Long-Term Assets $82.93M $87.31M $90.21M
YoY Change -8.99% -3.21% 55.3%
TOTAL ASSETS
Total Short-Term Assets $45.66M $51.08M $70.07M
Total Long-Term Assets $82.93M $87.31M $90.21M
Total Assets $128.6M $138.4M $160.3M
YoY Change -15.55% -13.66% -5.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.493M $1.422M $3.485M
YoY Change -39.04% -59.2% 4.94%
Accrued Expenses $7.382M $5.147M $6.590M
YoY Change -12.39% -21.9% 128.58%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $8.875M $8.339M $12.33M
YoY Change -18.39% -32.36% 98.71%
LONG-TERM LIABILITIES
Long-Term Debt $13.25M $13.17M $16.88M
YoY Change -39.7% -21.98% 42.72%
Other Long-Term Liabilities $15.51M $16.00M $17.04M
YoY Change -15.28% -6.11% 2961.14%
Total Long-Term Liabilities $28.76M $13.17M $33.92M
YoY Change -28.6% -61.18% 173.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.875M $8.339M $12.33M
Total Long-Term Liabilities $28.76M $13.17M $33.92M
Total Liabilities $38.55M $38.73M $48.28M
YoY Change -26.4% -19.77% 110.47%
SHAREHOLDERS EQUITY
Retained Earnings -$91.80M -$81.10M -$41.71M
YoY Change 66.91% 94.43% 972.01%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $90.04M $99.65M $112.0M
YoY Change
Total Liabilities & Shareholders Equity $128.6M $138.4M $160.3M
YoY Change -15.55% -13.66% -5.26%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$10.66M -$10.15M -$22.47M
YoY Change -19.84% -54.82% 591.29%
Depreciation, Depletion And Amortization $1.611M $1.300M $400.0K
YoY Change 80.4% 225.0% -20.0%
Cash From Operating Activities -$2.782M -$4.380M -$8.332M
YoY Change -65.35% -47.43% 72.26%
INVESTING ACTIVITIES
Capital Expenditures $312.0K $970.0K -$6.582M
YoY Change -93.4% -114.74% 68.47%
Acquisitions
YoY Change
Other Investing Activities $197.0K $0.00
YoY Change
Cash From Investing Activities -$115.0K -$970.0K -$6.582M
YoY Change -97.57% -85.26% 68.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -621.0K 13.63M 35.00K
YoY Change -112.08% 38842.86% -102.77%
NET CHANGE
Cash From Operating Activities -2.782M -4.380M -8.332M
Cash From Investing Activities -115.0K -970.0K -6.582M
Cash From Financing Activities -621.0K 13.63M 35.00K
Net Change In Cash -3.518M 8.280M -14.88M
YoY Change -53.83% -155.65% 48.66%
FREE CASH FLOW
Cash From Operating Activities -$2.782M -$4.380M -$8.332M
Capital Expenditures $312.0K $970.0K -$6.582M
Free Cash Flow -$3.094M -$5.350M -$1.750M
YoY Change -75.75% 205.71% 88.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
415000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001850902
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40538
dei Entity Registrant Name
EntityRegistrantName
ALPHA TEKNOVA, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3368109
dei Entity Address Address Line1
EntityAddressAddressLine1
2451 Bert Dr.
dei Entity Address City Or Town
EntityAddressCityOrTown
Hollister
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95023
dei City Area Code
CityAreaCode
831
dei Local Phone Number
LocalPhoneNumber
637-1100
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
TKNO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40727780
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8169000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10692000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28817000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33529000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6697000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5922000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19856000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18163000
CY2023Q3 us-gaap Gross Profit
GrossProfit
1472000
CY2022Q3 us-gaap Gross Profit
GrossProfit
4770000
us-gaap Gross Profit
GrossProfit
8961000
us-gaap Gross Profit
GrossProfit
15366000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1397000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1925000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4256000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5867000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2412000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2397000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6929000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6592000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6138000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6502000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19426000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20856000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
287000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
287000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
860000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
861000
CY2023Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2022Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
2195000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
16613000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
16613000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
10234000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
27724000
us-gaap Operating Expenses
OperatingExpenses
33666000
us-gaap Operating Expenses
OperatingExpenses
50789000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8762000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-22954000
us-gaap Operating Income Loss
OperatingIncomeLoss
-24705000
us-gaap Operating Income Loss
OperatingIncomeLoss
-35423000
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-791000
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
70000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1006000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
85000
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-824000
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-824000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
233000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
36000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
417000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
36000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1382000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
106000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1413000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
121000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10144000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22848000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26118000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35302000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-374000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1128000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10153000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-22474000
us-gaap Net Income Loss
NetIncomeLoss
-26124000
us-gaap Net Income Loss
NetIncomeLoss
-34174000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.8
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.8
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.22
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29956930
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29956930
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28090267
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28090267
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28810068
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28810068
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28059897
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28059897
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32079000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42236000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
43000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
22000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5160000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4261000
CY2023Q3 us-gaap Inventory Net
InventoryNet
11468000
CY2022Q4 us-gaap Inventory Net
InventoryNet
12247000
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
22000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2371000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2374000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
51078000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
61140000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51579000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51577000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17080000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19736000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16696000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17556000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1952000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2252000
CY2023Q3 us-gaap Assets
Assets
138385000
CY2022Q4 us-gaap Assets
Assets
152261000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1422000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2449000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5147000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6203000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1770000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2223000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8339000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10875000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1228000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1223000
CY2023Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
125000
CY2022Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
191000
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13168000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
21976000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15873000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18111000
CY2023Q3 us-gaap Liabilities
Liabilities
38733000
CY2022Q4 us-gaap Liabilities
Liabilities
52376000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
490000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
490000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40727780
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40727780
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28179423
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28179423
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
0
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
180782000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
154891000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81130000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-55006000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
99652000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
99885000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
138385000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
152261000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
86208000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1035000
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
22562000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10153000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
99652000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
133467000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
968000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
35000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-22474000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
111996000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
99885000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3115000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
76000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
138000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
22562000
us-gaap Net Income Loss
NetIncomeLoss
-26124000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
99652000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
143203000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2689000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
134000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
144000
us-gaap Net Income Loss
NetIncomeLoss
-34174000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
111996000
us-gaap Net Income Loss
NetIncomeLoss
-26124000
us-gaap Net Income Loss
NetIncomeLoss
-34174000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
21000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
34000
us-gaap Inventory Write Down
InventoryWriteDown
130000
us-gaap Inventory Write Down
InventoryWriteDown
178000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4049000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2272000
us-gaap Share Based Compensation
ShareBasedCompensation
3115000
us-gaap Share Based Compensation
ShareBasedCompensation
2689000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
5000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1125000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
159000
tkno Non Cash Lease Expense
NonCashLeaseExpense
86000
tkno Non Cash Lease Expense
NonCashLeaseExpense
256000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
210000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
2195000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
16613000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-824000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
721000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
949000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
667000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-649000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5107000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-22000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1068000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
694000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1083000
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-300000
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
996000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-948000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
969000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
815000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
343000
tkno Increase Decrease In Other Operating Assets And Liabilities
IncreaseDecreaseInOtherOperatingAssetsAndLiabilities
-66000
tkno Increase Decrease In Other Operating Assets And Liabilities
IncreaseDecreaseInOtherOperatingAssetsAndLiabilities
-61000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15922000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19371000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7622000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23419000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7622000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23419000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22915000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
10000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
tkno Proceeds From Financed Insurance Premium
ProceedsFromFinancedInsurancePremium
1004000
tkno Proceeds From Financed Insurance Premium
ProceedsFromFinancedInsurancePremium
0
tkno Repayment Of Financed Insurance Premiums
RepaymentOfFinancedInsurancePremiums
294000
tkno Repayment Of Financed Insurance Premiums
RepaymentOfFinancedInsurancePremiums
0
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5135000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
24000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
151000
tkno Payment Of Exit Fee Costs
PaymentOfExitFeeCosts
0
tkno Payment Of Exit Fee Costs
PaymentOfExitFeeCosts
135000
tkno Payment Of Atm Facility Costs
PaymentOfAtmFacilityCosts
-395000
tkno Payment Of Atm Facility Costs
PaymentOfAtmFacilityCosts
0
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81100000
CY2023Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
12100000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
76000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
134000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
138000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
144000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13420000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5127000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10124000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-37663000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42236000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
87518000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32112000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49855000
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Interest Paid Net
InterestPaidNet
1934000
us-gaap Interest Paid Net
InterestPaidNet
0
tkno Debt Issuance Costs Included In Accrued Liabilities
DebtIssuanceCostsIncludedInAccruedLiabilities
23000
tkno Debt Issuance Costs Included In Accrued Liabilities
DebtIssuanceCostsIncludedInAccruedLiabilities
0
tkno Offering Costs Included In Accounts Payable And Accrued Liabilities
OfferingCostsIncludedInAccountsPayableAndAccruedLiabilities
353000
tkno Offering Costs Included In Accounts Payable And Accrued Liabilities
OfferingCostsIncludedInAccountsPayableAndAccruedLiabilities
0
tkno Capitalized Property Plant And Equipment Included In Accounts Payable And Accrued Liabilities
CapitalizedPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities
205000
tkno Capitalized Property Plant And Equipment Included In Accounts Payable And Accrued Liabilities
CapitalizedPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities
3108000
tkno Recognition Of Operating Right Of Use Lease Asset
RecognitionOfOperatingRightOfUseLeaseAsset
-1137000
tkno Recognition Of Operating Right Of Use Lease Asset
RecognitionOfOperatingRightOfUseLeaseAsset
20318000
tkno Recognition Of Operating Lease Liabilities
RecognitionOfOperatingLeaseLiabilities
-1193000
tkno Recognition Of Operating Lease Liabilities
RecognitionOfOperatingLeaseLiabilities
20587000
us-gaap Nature Of Operations
NatureOfOperations
<p id="i_notes" style="text-indent:0;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 1. Nature of th</span><span style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">e Business</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Alpha Teknova, Inc. (referred to herein as the Company or Teknova), produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Product offerings include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. Teknova supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions, with catalog and custom, made-to-order products.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Teknova manufactures its products at its Hollister, California, headquarters and stocks inventory of raw materials, components, and finished goods at that location. The Company ships products directly from its warehouse in Hollister, California.</span></p>
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10200000
us-gaap Net Income Loss
NetIncomeLoss
-26100000
CY2023Q3 tkno Working Captial
WorkingCaptial
42700000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32100000
tkno Reduction In Workforce Policytext Blocks
ReductionInWorkforcePolicytextBlocks
<p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reduction in Workforce</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On February 1, 2023, the Company carried out a reduction in workforce of approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> positions, aimed at reducing operating expenses. The Company incurred $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of costs in connection with the reduction in workforce related to severance pay and other termination benefits. The costs associated with the reduction in workforce were recorded in the quarter ended March 31, 2023, in general and administrative expenses.</span></p>
CY2023Q1 tkno Reduction In Workforce Of Positions
ReductionInWorkforceOfPositions
40
CY2023Q1 tkno Severance And Other Related Termination Benefits
SeveranceAndOtherRelatedTerminationBenefits
700000
CY2023Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22915000
tkno Offering Expenses
OfferingExpenses
400000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32079000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42236000
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
33000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32112000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42236000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8169000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10692000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28817000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33529000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8169000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10692000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28817000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33529000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51577000
CY2023Q3 us-gaap Depreciation
Depreciation
1300000
us-gaap Depreciation
Depreciation
3200000
CY2022Q3 us-gaap Depreciation
Depreciation
400000
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8155000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8368000
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
58000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
186000
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
3255000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
3693000
CY2023Q3 us-gaap Inventory Net
InventoryNet
11468000
CY2022Q4 us-gaap Inventory Net
InventoryNet
12247000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55275000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
32383000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6711000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4520000
CY2023Q3 tkno Property Plant And Equipment After Depreciation
PropertyPlantAndEquipmentAfterDepreciation
48564000
CY2022Q4 tkno Property Plant And Equipment After Depreciation
PropertyPlantAndEquipmentAfterDepreciation
27863000
CY2023Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
3015000
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
23714000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51579000
us-gaap Depreciation
Depreciation
1400000
CY2023Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
900000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
900000
CY2022Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
400000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1100000
CY2023Q2 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
2200000
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
700000
us-gaap Operating Lease Expense
OperatingLeaseExpense
2200000
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
800000
us-gaap Operating Lease Expense
OperatingLeaseExpense
2500000
CY2023Q3 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
600000
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
2100000
CY2022Q3 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
700000
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
2100000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
647000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2601000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2354000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2413000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2416000
CY2023Q3 tkno Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
11917000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
22348000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4705000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
17643000
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
22099000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5403000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16696000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
22099000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4543000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17556000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000
CY2022Q4 tkno Cash Received Under The Term Loan2
CashReceivedUnderTheTermLoan2
5135000
CY2022Q4 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
5000000
CY2023Q2 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
10000000
CY2023Q4 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
10000000
CY2022Q4 tkno Cash Received Under The Term Loan3
CashReceivedUnderTheTermLoan3
5000000
CY2022Q2 us-gaap Line Of Credit Facility Description
LineOfCreditFacilityDescription
If any advance under the Term Loan was prepaid at any time, the prepayment fee was based on the amount being prepaid and an applicable percentage amount, such as 3%, 2%, or 1%, based on the date the prepayment was made after the closing date of the Term Loan.
CY2022Q2 tkno Term Loan Exit Fee Rate
TermLoanExitFeeRate
0.05
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P3Y3M18D
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
288000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1148000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1148000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1148000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
45000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3777000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3068000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2796000
CY2023Q3 tkno Accrued Liabilities Property Plant And Equipment Current
AccruedLiabilitiesPropertyPlantAndEquipmentCurrent
110000
CY2022Q4 tkno Accrued Liabilities Property Plant And Equipment Current
AccruedLiabilitiesPropertyPlantAndEquipmentCurrent
1966000
CY2023Q3 us-gaap Deferred Revenue
DeferredRevenue
24000
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
198000
CY2023Q3 tkno Insurance Premiums And Accrued Interest
InsurancePremiumsAndAccruedInterest
709000
CY2022Q4 tkno Insurance Premiums And Accrued Interest
InsurancePremiumsAndAccruedInterest
0
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1236000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1243000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5147000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6203000
CY2023Q3 tkno Insurance Premiums Paid
InsurancePremiumsPaid
1200000
CY2023Q3 tkno Annual Interest Rate To Finance For Insurance Premiums
AnnualInterestRateToFinanceForInsurancePremiums
0.0774
CY2023Q3 tkno Insurance Premiums Down Payment
InsurancePremiumsDownPayment
200000
CY2023Q3 tkno Insurance Premiums Frequency Of Payments
InsurancePremiumsFrequencyOfPayments
300000
CY2023Q3 tkno Insurance Premiums And Accrued Interest
InsurancePremiumsAndAccruedInterest
700000
CY2022Q2 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
5000000
CY2021Q1 tkno Cash Received Under The Term Loan
CashReceivedUnderTheTermLoan
12000000
CY2022Q2 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
40135000
tkno Net Revenue Requirement For The Financial Covenant
NetRevenueRequirementForTheFinancialCovenant
42500000
CY2023Q3 us-gaap Debt Instrument Covenant Description
DebtInstrumentCovenantDescription
No. 4 also removed those requirements for the periods ending January 31, 2026 through March 31, 2027, instead requiring that for each applicable twelve-month period ending after December 31, 2025, the Company’s minimum net revenue requirement will be determined by MidCap in its reasonable discretion in consultation with the Company’s senior management and based on financial statements and projections delivered to MidCap in accordance with the financial reporting requirements in the Amended Credit Agreement, so long as the minimum net revenue requirements for those periods shall not be less than the greater of (x) the applicable minimum net revenue requirement for the twelve-month period ending on the last day of the immediately preceding month and (y) $50.0
CY2023Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
12135000
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
22135000
CY2023Q3 tkno Debt Instrument Cumulative Accretion Of Exit Fee
DebtInstrumentCumulativeAccretionOfExitFee
1192000
CY2022Q4 tkno Debt Instrument Cumulative Accretion Of Exit Fee
DebtInstrumentCumulativeAccretionOfExitFee
161000
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
159000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
320000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
13168000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
21976000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3539000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6068000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2528000
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
12135000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1035000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
968000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3115000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2689000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-400000
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.016
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1100000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.032
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10153000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-22474000
us-gaap Net Income Loss
NetIncomeLoss
-26124000
us-gaap Net Income Loss
NetIncomeLoss
-34174000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29956930
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29956930
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28090267
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28090267
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28810068
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28810068
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28059897
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28059897
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.34
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.34
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.8
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.8
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.91
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.91
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.22
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.22

Files In Submission

Name View Source Status
0000950170-23-063053-index-headers.html Edgar Link pending
0000950170-23-063053-index.html Edgar Link pending
0000950170-23-063053.txt Edgar Link pending
0000950170-23-063053-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tkno-20230930.htm Edgar Link pending
tkno-20230930.xsd Edgar Link pending
tkno-ex31_1.htm Edgar Link pending
tkno-ex31_2.htm Edgar Link pending
tkno-ex32_1.htm Edgar Link pending
tkno-20230930_cal.xml Edgar Link unprocessable
tkno-20230930_def.xml Edgar Link unprocessable
tkno-20230930_lab.xml Edgar Link unprocessable
tkno-20230930_pre.xml Edgar Link unprocessable
tkno-20230930_htm.xml Edgar Link completed